1 | | Primary Avenida Tenente Valadim 17, 2F | Torres Vedras | PT | | Targeted Therapeutics | N/A | Raúl G. Saraiva, PhD | Biomedical Investment Manager at Portugal Ventures |
2 | | Primary 94/H 9th Cross, 13th Main, RMV Extension, Sadashivanagar | Bangalore | IN | | Telehealth Integrated Digital Therapeutics Platform | N/A | Kaif Salma | Senior Dietitian @7sugar.com |
3 | | Primary | Heidelberg | DE | | Digital Therapeutics | N/A | Abdullah Khalil | CTO at Midaia | Engineering Manager at Discovergy |
4 | | Primary Hans-Bunte-Str. 19 | Freiburg | DE | | Unlocking Novel Therapeutics | N/A | andreas schaaf | managing director and chief strategy officer |
5 | | Primary | Los Altos | US | | Precision Therapeutics For Brain Health | N/A | Lauren Blake, Ph.D. | Data Scientist at Alto Neuroscience |
6 | | Primary Alderley Park | Alderley Park | GB | | Developing Novel Bacterial Rna-Targeted Therapeutics | N/A | Fraser Murray | Chief Executive Officer at Pandeia Therapeutics and Round Earth |
7 | | Primary | Cambridge | US | | Redefining Cancer Therapeutics | N/A | scott robinson | president and chief strategy officer |
8 | | Primary Kloosterstraat 9 RE0333/RE0207 | Oss | NL | | Mrna Therapeutics | N/A | Ron Byron PhD | Ekoy Investment Partners -Teamwork makes the dream work (John Maxwell) |
9 | | Primary 704 Quince Orchard Road | Gaithersburg | US | | Rna Therapeutics | N/A | Anthony Saleh | CEO at miRecule, Inc |
10 | | Primary Im Neuenheimer Feld 515 | Heidelberg | DE | | Transforming Ocular Therapeutics | N/A | daniela willen | director, clinical development ophthalmology |
11 | | Primary 45 Caprice Ct. | Jupiter | US | | Transforming Therapeutics | N/A | Striechman Ron | Member Of The Board Of Advisors at Beacon-Accelerator |
12 | | Primary 601 Genome Way Suite 2100 | Huntsville | US | | Linking Diagnostics To Therapeutics™ | N/A | Kym Julius Creekmore, CHC | N/A |
13 | | Primary 3401 Market St | Philadelphia | US | | Discovering Novel Antiviral Therapeutics | N/A | Michael Saporito | Biopharmaceutical Consultant |
14 | | Primary 200 Crescent Court Suite 455 | Dallas | US | | Hedge Fund Focused On Biotech/Pharma/Therapeutics | N/A | Neil Shahrestani, MD | Portfolio Manager - Biotech/Therapeutics |
15 | | Sinbuk-ro, Sinbuk-eup 61-20 | Gagnam-gu | KR | | From Aesthetics To Therapeutics | N/A | Monica Kyong Ye Cho | HUGEL Head Of Legal/Compliance |
16 | | Primary 11 Scorsbey Road | Bayswater | AU | | Delivering Quality Therapeutics | N/A | Timothee Murcier | Area Manager Asia and Middle East at Fairmont Medical Products Pty Ltd |
17 | | Primary London Bioscience Innovation Centre, 2 Royal College Street | LONDON | GB | | Innovative Ocular and Cancer Therapeutics | N/A | Salman Rahman | Commercial Lead at University of Hertfordshire--------President and Co-founder of VASGEN LIMITED |
18 | | Primary | Zurich | CH | | Antibacterial Therapeutics | N/A | Gunter Festel | Entrepreneur / Festel Capital / Founding Angel / Professor TU Berlin |
19 | | Primary St. Alban-Anlage 44 | Basel | CH | | Selective Mode Antimicrobial Resistance Therapeutics | N/A | Frank Otto Gombert | CEO bei Selmod |
20 | | Primary | Sydney | AU | | Advanced Therapeutics Within Everyone's Reach | N/A | Anthony Priyashantha Boteju | Head Of Marketing at Celltrion Healthcare Australia Pty Ltd |